Alpha 2.0
Login Register
» Authors » J A Langendijk

J A Langendijk

Explore the profile of J A Langendijk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 74
Citations 1275
Followers 0
Related Specialties
Oncology
Radiology
Biophysics
Top 10 Co-Authors
C R Leemans
B J Slotman
J M de Jong
I M Verdonck-de Leeuw
J H Maduro
E F Wouters
G P ten Velde
S Siesling
B F A M van der Laan
E Schuit
Published In
Radiother Oncol
Ann Oncol
Phys Med Biol
Clin Transl Radiat Oncol
Oral Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Supportive care needs among head and neck cancer patients in the recovery phase from 6 months to 2 years after treatment: which factors matter?
Molenaar D, Verdonck-de Leeuw I, Lissenberg-Witte B, Takes R, de Bree R, Langendijk J, et al.
J Cancer Surviv . 2025 Feb; PMID: 39928280
Purpose: To investigate which demographic, personal, clinical, physical, psychological, social, lifestyle, and cancer-related quality of life (QoL) factors are associated with (changes in) supportive care needs (SCNs) from 6 months...
2.
Normal tissue complication probability model predicting taste impairment in head and neck cancer patients: Evaluating the taste bud bearing tongue mucosa as a predictor
Neh H, de Vette S, Stoffers R, Zhou G, van Ooijen P, Sijtsema N, et al.
Radiother Oncol . 2025 Jan; 205:110746. PMID: 39884394
Background/purpose: Taste impairment is a common yet complex toxicity of head and neck cancer (HNC) radiotherapy treatment that may affect quality of life of survivors. This study aimed to predict...
3.
Pelvic lymph node motion during cone-beam computed tomography guided stereotactic radiotherapy
Janssen J, Staal F, Langendijk J, Both S, Brouwer C, Aluwini S
Clin Transl Radiat Oncol . 2024 May; 47:100794. PMID: 38798748
Background And Purpose: Stereotactic body radiotherapy (SBRT) is increasingly applied for pelvic lymph node recurrence. Thus far, knowledge on pelvic lymph node motion during CBCT-guided SBRT is lacking and the...
4.
Evaluation of a new two-step frailty assessment of head and neck patients in a prospective cohort
Padovan B, Bijl M, Langendijk J, van der Laan H, van Dijk B, Festen S, et al.
Eur Arch Otorhinolaryngol . 2024 Apr; 281(8):4291-4304. PMID: 38653824
Purpose: Assessing frailty, in head and neck cancer (HNC) patients is key when choosing appropriate treatment. Optimal screening is challenging, as it should be feasible and should avoid over-referral for...
5.
External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts
Berbee M, Muijs C, Voncken F, Wee L, Sosef M, van Etten B, et al.
Radiother Oncol . 2023 Nov; 190:109979. PMID: 37949374
Purpose/objective: Chemo-radiotherapy can improve the oncological outcome of esophageal cancer (EC) patients, but may cause long term radiation-induced toxicity, including an increased risk of non-cancer related death. For lung cancer...
6.
Comparing supervised and semi-supervised machine learning approaches in NTCP modeling to predict complications in head and neck cancer patients
Spiero I, Schuit E, Wijers O, Hoebers F, Langendijk J, Leeuwenberg A
Clin Transl Radiat Oncol . 2023 Oct; 43:100677. PMID: 37822705
Background And Purpose: Head and neck cancer (HNC) patients treated with radiotherapy often suffer from radiation-induced toxicities. Normal Tissue Complication Probability (NTCP) modeling can be used to determine the probability...
7.
Patients' needs in proton therapy: A survey among ten European facilities
Mazzola G, Bergamaschi L, Pedone C, Vincini M, Pepa M, Zaffaroni M, et al.
Clin Transl Radiat Oncol . 2023 Sep; 43:100670. PMID: 37736140
Aims: The number of Proton Therapy (PT) facilities is still limited worldwide, and the access to treatment could be characterized by patients' logistic and economic challenges. Aim of the present...
8.
A comparison of cardiovascular and pulmonary morbidities and risk factors in breast cancer survivors compared to an age-matched female control group in the Lifelines prospective population cohort
Spoor D, van den Bogaard V, Sijtsema N, van der Meer P, de Bock G, Langendijk J, et al.
Breast . 2023 Jun; 70:49-55. PMID: 37331094
Purpose: To provide more insight into late treatment-related toxicities among breast cancer (BC) survivors by comparing morbidities and risk factors between BC survivors and age-matched controls. Materials And Methods: All...
9.
Planned dose of intensity modulated proton beam therapy versus volumetric modulated arch therapy to tooth-bearing regions
Alberga J, Meijer J, Raghoebar G, Langendijk J, Korfage A, Steenbakkers R, et al.
Oral Oncol . 2023 Apr; 140:106392. PMID: 37084567
Background: Intensity modulated proton beam therapy (IMPT) for head and neck cancer offers dosimetric benefits for the organs at risk when compared to photon-based volumetric modulated arch therapy (VMAT). However,...
10.
Supraventricular cardiac conduction system exposure in breast cancer patients treated with radiotherapy and association with heart and cardiac chambers doses
Errahmani M, Locquet M, Broggio D, Spoor D, Jimenez G, Camilleri J, et al.
Clin Transl Radiat Oncol . 2022 Nov; 38:62-70. PMID: 36388244
Purpose: To assess sinoatrial node (SAN) and atrioventricular node (AVN) doses for breast cancer (BC) patients treated with 3D-CRT and evaluate whether "large" cardiac structures (whole heart and four cardiac...